Application

18589995 · INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS

Filed 2024-02-28 · Pending The official file ↗ · Art unit 1614 · Examiner Haejin S Park Typical · CPC A61K 9/0075 · Lonza Bend Inc. · Klarquist Sparkman, LLP (Bend Research)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

23.3 mo

to disposition n/a

Statutes raised

103 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.